{"id":"W3008901859","doi":"10.1002/cpdd.773","title":"Absolute Bioavailability of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Medicine; Bioavailability; Mutation; Internal medicine; Cancer research; Oncology; Pharmacology; Cancer; Genetics; Metastatic melanoma; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987153,0.0002031479,0.0003896515,0.00005313594,0.00003496135,0.00000475635,0.0002480272,0.0001725744,0.00006266226],"category_scores_gemma":[0.0001405646,0.0001816068,0.00006446832,0.0001961853,0.0002665583,0.000008324729,0.0001961071,0.0002350348,0.00002591686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003819976,"about_ca_system_score_gemma":0.0003589571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001019295,"about_ca_topic_score_gemma":0.00003424761,"domain_scores_codex":[0.9977996,0.0002759442,0.0009003503,0.0005605985,0.000154235,0.0003092491],"domain_scores_gemma":[0.9992395,0.0001186769,0.0001990395,0.0001468859,0.0001432259,0.0001526446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002677216,0.001819499,0.968222,0.0001268144,0.0002440726,0.00008104715,0.003348937,0.0007422973,0.01163732,0.0000161533,0.006149479,0.004935181],"study_design_scores_gemma":[0.0069459,0.0007312906,0.8901299,0.00003738681,0.00002769224,0.000001331065,0.0001373711,0.0000842524,0.08985344,0.00001344221,0.01170167,0.0003363613],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980971,0.00009401143,0.00003940207,0.0005349955,0.0001972962,0.0007175207,0.00003016991,0.00001053147,0.000278951],"genre_scores_gemma":[0.9959898,0.00003209421,0.001361427,0.002157465,0.00009973479,0.0000919201,0.0001855617,0.00001672057,0.00006525374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07821611,"threshold_uncertainty_score":0.7405709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01810976022212002,"score_gpt":0.2810174184975781,"score_spread":0.262907658275458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}